266 related articles for article (PubMed ID: 36336688)
1. Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.
Obnial JC; Suzuki M; Escuadra CJ; Austria JT; Ponce MJM; Cunanan E
Glob Health Res Policy; 2022 Nov; 7(1):42. PubMed ID: 36336688
[TBL] [Abstract][Full Text] [Related]
2. Worldwide inverse correlation between Bacille Calmette-Guérin (BCG) immunization and COVID-19 mortality.
Li WX
Infection; 2021 Jun; 49(3):463-473. PubMed ID: 33495884
[TBL] [Abstract][Full Text] [Related]
3. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
4. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
6. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
8. Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
Ledesma JR; Lurie P; Yorlets RR; Daly G; Chrysanthopoulou S; Lurie MN
PLoS One; 2022; 17(9):e0274900. PubMed ID: 36125984
[TBL] [Abstract][Full Text] [Related]
9. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.
Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A
Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255
[TBL] [Abstract][Full Text] [Related]
10. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
11. Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial.
Blok BA; de Bree LCJ; Diavatopoulos DA; Langereis JD; Joosten LAB; Aaby P; van Crevel R; Benn CS; Netea MG
Clin Infect Dis; 2020 Jan; 70(3):455-463. PubMed ID: 30919883
[TBL] [Abstract][Full Text] [Related]
12. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
14. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
15. Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden.
de Chaisemartin C; de Chaisemartin L
Clin Infect Dis; 2021 May; 72(10):e501-e505. PubMed ID: 32829400
[TBL] [Abstract][Full Text] [Related]
16. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
Higgins JP; Soares-Weiser K; López-López JA; Kakourou A; Chaplin K; Christensen H; Martin NK; Sterne JA; Reingold AL
BMJ; 2016 Oct; 355():i5170. PubMed ID: 27737834
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of booster BCG vaccination in preventing Covid-19 infection.
Amirlak L; Haddad R; Hardy JD; Khaled NS; Chung MH; Amirlak B
Hum Vaccin Immunother; 2021 Nov; 17(11):3913-3915. PubMed ID: 34403297
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the potential role of BCG and MMR vaccines in COVID-19.
Bayram Z; Musharrafieh U; Bizri AR
Sci Prog; 2022; 105(2):368504221105172. PubMed ID: 35848578
[TBL] [Abstract][Full Text] [Related]
19. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants.
Zimmermann P; Donath S; Perrett KP; Messina NL; Ritz N; Netea MG; Flanagan KL; van der Klis FRM; Curtis N;
Vaccine; 2019 Jun; 37(28):3735-3744. PubMed ID: 31153688
[TBL] [Abstract][Full Text] [Related]
20. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.
Nissen TN; Birk NM; Smits G; Jeppesen DL; Stensballe LG; Netea MG; van der Klis F; Benn CS; Pryds O;
Vaccine; 2017 Apr; 35(16):2084-2091. PubMed ID: 28318766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
